Pharma Firms Look to Expand Artificial Intelligence Across Drug Development

SEOUL, Feb. 11 (Korea Bizwire) —  South Korea’s pharmaceutical and biotechnology companies are preparing to deepen their use of artificial intelligence, seeking to extend its role beyond early-stage drug discovery and into the full life cycle of medicine development. While AI has become a familiar tool in the domestic industry, its application remains largely confined to [...]